Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

Andrew M. Blumenfeld, Kerry Knievel, Aubrey Manack Adams, Lawrence Severt, Matthew Butler, Hongxin Lai, David W. Dodick

Research output: Contribution to journalArticlepeer-review

Keywords

  • Acute treatment
  • Concomitant therapies
  • Migraine
  • Preventive treatment
  • Ubrogepant

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials'. Together they form a unique fingerprint.

Cite this